Hunan Hansen Pharmaceutical (002412.SZ)Engelcare tablets have completed drug registration.
Hanshen Pharmaceuticals (002412.SZ) announced that the company recently received approval and issuance from the National Medical Products Administration for the chemical pharmaceutical...
Hunan Hansen Pharmaceutical (002412.SZ) announced that the company has recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for the chemical drug "Empagliflozin Tablets". This drug is used for the treatment of type 2 diabetes, as well as for adult patients with symptomatic chronic heart failure to reduce the risk of hospitalization due to heart failure.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
